Differential effects of Bifidobacterium pseudolongum strain patronus and metronidazole in the rat gut

Applied and Environmental Microbiology

Volumn 75, Issue 2, 2009, Pages 381-386

  Vasquez, Nadia ^a   Suau, Antonia ^a   Magne, Fabien ^a   Pochart, Philippe ^a   Pélissier, Marie Agnès ^a  

^a Bioinformatique et Chimie Moléculaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

16S RRNA GENES; ANTIOXIDANT EFFECTS; BIFIDOBACTERIA; BIFIDOBACTERIUM; CECAL MUCOSAS; DIFFERENTIAL EFFECTS; EXPERIMENTAL MODELS; IN CONTROLS; METRONIDAZOLE; MICROBIOTA; OXIDATION PROCESSES; OXIDATIVE DAMAGES; SMALL BOWELS;

OXIDATION; PROTEINS;

RATS;

CARBONYL DERIVATIVE; GENBOX ANAER; GLUTATHIONE; MALONALDEHYDE; METRONIDAZOLE; PROBIOTIC AGENT; RNA 16S; UNCLASSIFIED DRUG;

BACTERIUM; ENVIRONMENTAL STRESS; MODELING; OXIDATION; RODENT; STOMACH CONTENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIFIDOBACTERIUM; BIFIDOBACTERIUM PSEUDOLONGUM; CECUM; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; DNA PURIFICATION; DRUG EFFECT; EXPERIMENTAL MODEL; FEEDING; INTESTINE; INTESTINE MUCOSA; MALE; MICROFLORA; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATIVE STRESS; RAT; SMALL INTESTINE;

ANIMALS; ANTIOXIDANTS; BIFIDOBACTERIUM; BIODIVERSITY; CECUM; DNA, BACTERIAL; DNA, RIBOSOMAL; GASTROINTESTINAL TRACT; GENES, RRNA; INTESTINAL MUCOSA; METRONIDAZOLE; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PHYLOGENY; PROBIOTICS; PROTEINS; RATS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM PSEUDOLONGUM; RATTUS;

EID: 58149389297     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01731-08     Document Type: Article

References (55)

1. Castillo, M., S. M. Martin-Orue, E. G. Manzanilla, I. Badiola, M. Martin, and J. Gasa. 2006. Quantification of total bacteria, enterobacteria and lactobacilli populations in pig digesta by real-time PCR. Vet. Microbiol. 114:165-170.
2. Conte, M. P., S. Schippa, I. Zamboni, M. Penta, F. Chiarini, L. Seganti, J. Osborn, P. Falconieri, O. Borrelli, and S. Cucchiara. 2006. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55:1760-1767.
3. Corfield, A. P., N. Myerscough, R. Longman, P. Sylvester, S. Arul, and M. Pignatelli. 2000. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 47:589-594.
4. da S. Queiroz-Monici, K., G. E. A. Costa, N. da Silva, S. M. P. M. Reis, and A. C. de Oliveira. 2005. Bifidogenic effect of dietary fiber and resistant starch from leguminous on the intestinal microbiota of rats. Nutrition 21:602-608.
5. Delroisse, J. M., A. L. Boulvin, I. Parmentier, R. D. Dauphin, M. Vandenbol, and D. Portetelle. 2008. Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol. Res. 163:663-670.
6. Duncan, S. H., G. E. Lobley, G. Holtrop, J. Ince, A. M. Johnstone, P. Louis, and H. J. Flint. 2008. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (London) 32:1720-1724.
7. Farhadi, A., A. Keshavarzian, L. R. Fitzpatrick, E. Mutlu, Y. Zhang, and A. Banan. 2002. Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide. Dig. Dis. Sci. 47:1342-1348.
8. Freeman, C. D., N. E. Klutman, and K. C. Lamp. 1997. Metronidazole. A therapeutic review and update. Drugs 54:679-708.
9. Gavini, F., A. M. Pourcher, C. Neut, D. Monget, C. Romond, C. Oger, and D. Izard. 1991. Phenotypic differentiation of bifidobacteria of human and animal origins. Int. J. Syst. Bacteriol. 41:548-557.
10. Gibson, G. R., and X. Wang. 1994. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bacteriol. 77:412-420.
11. Gionchetti, P., F. Rizzello, K. M. Lammers, C. Morselli, L. Sollazzi, S. Davies, R. Tambasco, C. Calabrese, and M. Campieri. 2006. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J. Gastroenterol. 12:3306-3313.
12. Grisham, M. B. 1994. Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859-861.
13. Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
14. Hicks, R. E., R. I. Amann, and D. A. Stahl. 1992. Dual staining of natural bacterioplankton with 4′,6-diamidino-2-phenylindole and fluorescent oligonucleotide probes targeting kingdom-level 16S rRNA sequences. Appl. Environ. Microbiol. 58:2158-2163.
15. Hoensch, H., I. Morgenstern, G. Petereit, M. Siepmann, W. H. Peters, H. M. Roelofs, and W. Kirch. 2002. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut 50:235-240.
16. Hooper, L. V., and J. I. Gordon. 2001. Commensal host-bacterial relationships in the gut. Science 292:1115-1118.
17. Ito, M., K. Ohishi, Y. Yoshida, W. Yokoi, and H. Sawada. 2003. Antioxidative effects of lactic acid bacteria on the colonic mucosa of iron-overloaded mice. J. Agric. Food Chem. 51:4456-4460.
18. Ito, M., H. Sawada, K. Ohishi, Y. Yoshida, W. Yokoi, T. Watanabe, and T. Yokokura. 2001. Suppressive effects of bifidobacteria on lipid peroxidation in the colonic mucosa of iron-overloaded mice. J. Dairy Sci. 84:1583-1589.
19. Kalliomaki, M., M. C. Collado, S. Salminen, and E. Isolauri. 2008. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 87:534-538.
20. Kane, M. D., L. K. Poulsen, and D. A. Stahl. 1993. Monitoring the enrichment and isolation of sulfate-reducing bacteria by using oligonucleotide hybridization probes designed from environmentally derived 16S rRNA sequences. Appl. Environ. Microbiol. 59:682-686.
21. Keshavarzian, A., A. Banan, A. Farhadi, S. Komanduri, E. Mutlu, Y. Zhang, and J. Z. Fields. 2003. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52:720-728.
22. Kleessen, B., L. Hartmann, and M. Blaut. 2003. Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br. J. Nutr. 89:597-606.
23. Kleessen, B., A. J. Kroesen, H. J. Buhr, and M. Blaut. 2002. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 9:1034-1041.
24. Lee, H. S., S. Y. Han, E. A. Bae, C. S. Huh, Y. T. Ahn, J. H. Lee, and D. H. Kim. 2008. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice. Int. Immunopharmacol. 8:574-580.
25. Levine, R. L., D. Garland, C. N. Oliver, A. Amici, I. Climent, A. G. Lenz, B. W. Ahn, S. Shaltiel, and E. R. Stadtman. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186:464-478.
26. Lih-Brody, L., S. R. Powell, K. P. Collier, G. M. Reddy, R. Cerchia, E. Kahn, G. S. Weissman, S. Katz, R. A. Floyd, M. J. McKinley, S. E. Fisher, and G. E. Mullin. 1996. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig. Dis. Sci. 41:2078-2086.
27. Lin, M. Y., and F. J. Chang. 2000. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig. Dis. Sci. 45:1617-1622.
28. Lin, M. Y., and C. L. Yen. 1999. Inhibition of lipid peroxidation by Lactobacillus acidophilus and Bifidobacterium longum. J. Agric. Food Chem. 47:3661-3664.
29. Lin, M. Y., and C. L. Yen. 1999. Reactive oxygen species and lipid peroxidation product-scavenging ability of yogurt organisms. J. Dairy Sci. 82:1629-1634.
30. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
31. Magne, F., M. Abely, F. Boyer, P. Morville, P. Pochart, and A. Suau. 2006. Low species diversity and high interindividual variability in faeces of preterm infants as revealed by sequences of 16S rRNA genes and PCR-temporal temperature gradient gel electrophoresis profiles. FEMS Microbiol. Ecol. 57:128-138.
32. Magne, F., W. Hachelaf, A. Suau, G. Boudraa, I. Mangin, M. Touhami, K. Bouziane-Nedjadi, and P. Pochart. 2006. A longitudinal study of infant faecal microbiota during weaning. FEMS Microbiol. Ecol. 58:563-571.
33. Maidak, B. L., J. R. Cole, T. G. Lilburn, Jr., C. T. Parker, P. R. Saxman, R. J. Farris, G. M. Garrity, G. J. Olsen, T. M. Schmidt, and J. M. Tiedje. 2001. The RDP-II (Ribosomal Database Project). Nucleic Acids Res. 29:173-174.
34. Mangin, I., A. Suau, F. Magne, D. Garrido, M. Gotteland, C. Neut, and P. Pochart. 2006. Characterization of human intestinal bifidobacteria using competitive PCR and PCR-TTGE. FEMS Microbiol. Ecol. 55:28-37.
35. Matsuda, H., Y. Fujiyama, A. Andoh, T. Ushijima, T. Kajinami, and T. Bamba. 2000. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J. Gastroenterol. Hepatol. 15:61-68.
36. Matsuki, T., K. Watanabe, J. Fujimoto, T. Takada, and R. Tanaka. 2004. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 70:7220-7228.
37. Moubareck, C., F. Gavini, L. Vaugien, M. J. Butel, and F. Doucet-Populaire. 2005. Antimicrobial susceptibility of bifidobacteria. J. Antimicrob. Chemother. 55:38-44.
38. Mylonaki, M., N. B. Rayment, D. S. Rampton, B. N. Hudspith, and J. Brostoff. 2005. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm. Bowel Dis. 11:481-487.
39. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358.
40. Osman, N., D. Adawi, S. Ahrne, B. Jeppsson, and G. Molin. 2004. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Dig. Dis. Sci. 49:320-327.
41. Pavlick, K. P., F. S. Laroux, J. Fuseler, R. E. Wolf, L. Gray, J. Hoffman, and M. B. Grisham. 2002. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic. Biol. Med. 33:311-322.
42. Pelissier, M. A., P. Marteau, and P. Pochart. 2007. Antioxidant effects of metronidazole in colonic tissue. Dig. Dis. Sci. 52:40-44.
43. Rezaie, A., R. D. Parker, and M. Abdollahi. 2007. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci. 52:2015-2021.
44. Rutgeerts, P., M. Hiele, K. Geboes, M. Peeters, F. Penninckx, R. Aerts, and R. Kerremans. 1995. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108:1617-1621.
45. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
46. Sartor, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620-1633.
47. Satokari, R. M., E. E. Vaughan, A. D. Akkermans, M. Saarela, and W. M. De Vos. 2001. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67:504-513.
48. Schultsz, C., F. M. Van Den Berg, F. W. Ten Kate, G. N. Tytgat, and J. Dankert. 1999. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 117:1089-1097.
49. Sedlak, J., and R. H. Lindsay. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25:192-205.
50. Sido, B., V. Hack, A. Hochlehnert, H. Lipps, C. Herfarth, and W. Droge. 1998. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 42:485-492.
51. Siems, W. G., H. Zollner, T. Grune, and H. Esterbauer. 1997. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J. Lipid Res. 38:612-622.
52. Suzuki, K., K. Sugimura, K. Hasegawa, K. Yoshida, A. Suzuki, K. Ishizuka, K. Ohtsuka, T. Honma, R. Narisawa, and H. Asakura. 2001. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand. J. Gastroenterol. 36:1301-1306.
53. Swidsinski, A., A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, and H. Lochs. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54.
54. Tanabe, S., Y. Kinuta, and Y. Saito. 2008. Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation. Int. J. Mol. Med. 22:181-185.
55. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL-X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.